Concepedia

Author

Erin E. O’Leary

Cook Research (United States)

Also Known As

Erin E. O'Leary, Erin E. O’Leary

18

Publications

1.2K

Citations

12

H-Index

15

Concepts

All Affiliations

Cook Research (United States)Stanford UniversityStanford MedicineNara Medical UniversityThe Jikei University Hospital
EE

About

Erin E. O’Leary is an author at Cook Research (United States) specializing in systems biology, cell biology, and signal transduction.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

86

2

Cell Biology

2

2

86

3

Cell Signaling

2

2

86

4

Cellular Physiology

1

1

13

5

Immunology

1

1

13

Erin E. O’Leary

×

13

Publications

1.2K

Citations

12

H-Index

YearCitations

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery

Michael D. Dake, Gary M. Ansel, Michael R. Jaff,

Circulation

2016

508

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Michael D. Dake, Gary M. Ansel, Michael R. Jaff,

Journal of the American College of Cardiology

2013

328

The Roles of Cbl-b and c-Cbl in Insulin-stimulated Glucose Transport

Jun Liu, Stephanie M. DeYoung, Joseph Hwang,

Journal of Biological Chemistry

2003

86

T-Cell Factor 4N (TCF-4N), a Novel Isoform of Mouse TCF-4, Synergizes with β-Catenin To Coactivate C/EBPα and Steroidogenic Factor 1 Transcription Factors

Jennifer A. Kennell, Erin E. O’Leary, Brian M. Gummow,

Molecular and Cellular Biology

2003

73

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan

Hiroyoshi Yokoi, Takao Ohki, Kimihiko Kichikawa,

JACC: Cardiovascular Interventions

2016

68

Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices

Michael D. Dake, Gary M. Ansel, Marc Bosiers,

CardioVascular and Interventional Radiology

2019

61

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results

Kimihiko Kichikawa, Shigeo Ichihashi, Hiroyoshi Yokoi,

CardioVascular and Interventional Radiology

2018

29

Two-Year Analysis of the Japanese Cohort From the Zilver PTX Randomized Controlled Trial Supports the Validity of Multinational Clinical Trials

Takao Ohki, Hiroyoshi Yokoi, Kimihiko Kichikawa,

Journal of Endovascular Therapy

2014

20

Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels—Results from the Zilver PTX Japan Post-Market Surveillance Study

Stefano Cipollari, Hiroyoshi Yokoi, Takao Ohki,

Journal of Vascular and Interventional Radiology

2017

18

Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan

Yukihisa Ogawa, Hiroyoshi Yokoi, Takao Ohki,

CardioVascular and Interventional Radiology

2017

15

Page 1